Net Income (Loss) Attributable to Parent in USD of Mural Oncology plc from Q1 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Mural Oncology plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2022 to Q3 2025.
  • Mural Oncology plc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$3.71M, a 88.3% increase year-over-year.
  • Mural Oncology plc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$119M, a 22.6% increase year-over-year.
  • Mural Oncology plc annual Net Income (Loss) Attributable to Parent for 2024 was -$129M, a 38.1% increase from 2023.
  • Mural Oncology plc annual Net Income (Loss) Attributable to Parent for 2023 was -$207M, a 9.29% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Mural Oncology plc Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$119M -$3.71M +$28.1M +88.3% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$147M -$48M -$16.4M -52% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-06
Q1 2025 -$131M -$33.1M -$2.22M -7.18% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-06
Q4 2024 -$129M -$34.3M +$25.3M +42.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-11
Q3 2024 -$154M -$31.8M +$19.5M +38.1% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 -$173M -$31.6M +$18.2M +36.6% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-06
Q1 2024 -$192M -$30.9M +$15.9M +34% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-06
Q4 2023 -$207M -$59.5M -$11M -22.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-11
Q3 2023 -$196M -$51.3M -$635K -1.25% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$196M -$49.8M -$6.47M -14.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$189M -$46.8M +$418K +0.88% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$190M -$48.6M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$50.6M Jul 1, 2022 Sep 30, 2022 10-Q 2023-12-14
Q2 2022 -$43.3M Apr 1, 2022 Jun 30, 2022 10-Q 2023-12-14
Q1 2022 -$47.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-12-14

Mural Oncology plc Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$129M +$78.9M +38.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 -$207M -$17.6M -9.29% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 -$190M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.